SCHEMBL6603618

SCHEMBL6603618

CC(C)CC1(c2ccccc2)CC(O)=CC(=O)O1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.38
LDHA P00338 3/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34
HCAR3 P49019 3/20 0.33
HCAR2 Q8TDS4 3/20 0.33
HSD11B1 P28845 4/20 0.33
CYP3A4 P08684 3/20 0.33
CYP2C9 P11712 3/20 0.33
MMP3 P08254 1/20 0.33
CASP1 P29466 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 1/20 0.33
ELANE P08246 1/20 0.32
CYP2C19 P33261 2/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6606239 0.86 EGFR (0.36) EGFRLDHAHCAR3HCAR2HSD11B1
SCHEMBL6605661 0.84 AKT1 (0.40) EGFRHSD11B1CYP3A4CYP2C9CYP2C19
SCHEMBL6175624 0.82 EGFR (0.38) EGFRLDHAHCAR3HCAR2CYP1A2
SCHEMBL6175283 0.80 EGFR (0.39) EGFRLDHAMEN1KMT2AATM
SCHEMBL6604509 0.80 EGFR (0.37) EGFRLDHAMEN1KMT2AHCAR3
SCHEMBL6606251 0.78 MMP2 (0.41) EGFRMEN1KMT2AHCAR3HCAR2
SCHEMBL6604162 0.78 ALDH1A1 (0.38) EGFRLDHAMEN1KMT2AHCAR3
SCHEMBL8007692 0.78 ALDH1A1 (0.38) EGFRLDHAMEN1KMT2AHCAR3
SCHEMBL6605717 0.78 EGFR (0.38) EGFRLDHAKMT2AHCAR3HCAR2
SCHEMBL6605064 0.77 MMP2 (0.43) EGFRMEN1KMT2ACYP2C9MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142887-B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE DAVIS & CO (US) 2004-04-07 EP disclosed
EP-0729463-B1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2002-05-22 EP disclosed
EP-1142887-A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE, DAVIS & COMPANY (US) 2001-10-10 EP disclosed
US-5936128-A BENZENETHIOL COMPOUNDS AS INTERMEDIATES; BACTERICIDES, VIRICIDES; HIV WARNER-LAMBERT COMPANY (US) 1999-08-10 US disclosed
US-5840751-A ADMINISTERING IN THE TREATMENT OF INFECTION OR DISEASE CAUSED BY A RETROVIRUS WARNER-LAMBERT COMPANY (US) 1998-11-24 US disclosed
US-5789440-A 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents WARNER-LAMBERT COMPANY (US) 1998-08-04 US disclosed
EP-0729463-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729464-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014012-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014011-A2 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed